PulseLine speaks with Paul Docherty from 3DMEDiTech about its role in supporting the Australian Government through the COVID-19 pandemic, and the Government’s plan to invest in Australia’s advanced manufacturing future.
The Australian Government has announced that MTPConnect will operate the new $47 million Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular disease.
PulseLine spoke with MedTech Europe's Manager of International Affairs, Diana Kanecka, about what the Australian MedTech sector can learn from the European Regulatory Landscape.
Baxter has a long history in the supply of aseptically compounded medications to patients across Australia and New Zealand. Through dedication to quality and...